Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Stock image by PDPics from PixabayA Flinders University study shows that bowel cancer survivors face an elevated risk of ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Since the introduction of widespread PSA blood testing, many prostate cancers are now caught at an earlier, localized stage before they have spread. Catching cancer early hugely improves survival ...

Health professionals and advocates shared experiences and insights on the critical importance of Black participation in ...

A large Department of Veterans Affairs cohort study revealed key racial differences in genomic alterations among men with metastatic prostate cancer.

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

City of Hope Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving ...

King Charles has shared a rare health update as he continues to undergo treatment following his cancer diagnosis.